Literature DB >> 25246599

Reply to "On the use of 2,5-dimethyl-pyrrol-1-yl-benzoic acid derivatives as EPH-ephrin antagonists".

Ronald C Desrosiers1, Alexander S Hahn2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25246599      PMCID: PMC4178713          DOI: 10.1128/JVI.02160-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  5 in total

1.  The platelet P2Y12 receptor contributes to granule secretion through Ephrin A4 receptor.

Authors:  Erik Tournoij; C Arnold Koekman; Vivian X Du; Mark Roest; Rob Ruijtenbeek; Frans L Moll; Jan-Willem N Akkerman
Journal:  Platelets       Date:  2012-01-24       Impact factor: 3.862

2.  The ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi's sarcoma–associated herpesvirus.

Authors:  Alexander S Hahn; Johanna K Kaufmann; Effi Wies; Elisabeth Naschberger; Julia Panteleev-Ivlev; Katharina Schmidt; Angela Holzer; Martin Schmidt; Jin Chen; Simone König; Armin Ensser; Jinjong Myoung; Norbert H Brockmeyer; Michael Stürzl; Bernhard Fleckenstein; Frank Neipel
Journal:  Nat Med       Date:  2012-06       Impact factor: 53.440

3.  Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors.

Authors:  Roberta Noberini; Mitchell Koolpe; Satyamaheshwar Peddibhotla; Russell Dahl; Ying Su; Nicholas D P Cosford; Gregory P Roth; Elena B Pasquale
Journal:  J Biol Chem       Date:  2008-08-26       Impact factor: 5.157

4.  On the use of 2,5-dimethyl-pyrrol-1-yl-benzoic acid derivatives as EPH-ephrin antagonists.

Authors:  Alessio Lodola; Matteo Incerti; Massimiliano Tognolini
Journal:  J Virol       Date:  2014-10       Impact factor: 5.103

5.  Binding of the Kaposi's sarcoma-associated herpesvirus to the ephrin binding surface of the EphA2 receptor and its inhibition by a small molecule.

Authors:  Alexander S Hahn; Ronald C Desrosiers
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.